PT  - JOURNAL ARTICLE
AU  - Daniel Garcia-Vicuña
AU  - Laida Esparza
AU  - Fermin Mallor
TI  - Hospital preparedness in epidemics by using simulation. The case of COVID-19
AID  - 10.1101/2020.08.12.20173328
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.12.20173328
4099  - http://medrxiv.org/content/early/2020/08/14/2020.08.12.20173328.short
4100  - http://medrxiv.org/content/early/2020/08/14/2020.08.12.20173328.full
AB  - This paper presents a discrete event simulation model to support the decision-making concerned with the short-term planning of the necessary hospital resources, especially Intensive Care Unit (ICU) beds, to face outbreaks, as the SARS-CoV-2. Being used as a short-term forecasting tool, the simulation model requires an accurate representation of the current system state and high fidelity in mimicking the system dynamics from that state. The two main components of the simulation model are the stochastic modeling of the admission of new patients and the patient flow through the hospital facilities. For the patient arrival process, we analyze different models based on growth curves of the twenty most affected countries (until June 15) and propose the use of the Gompertz curve. The length of stay is divided into several stages, each one modeled separately. We analyze the starting of the simulation model, which requires different procedures depending on the information available about the patients currently hospitalized. We also report the use of this simulation model during the COVID-19 outbreak in the Autonomous Community of Navarre, in Spain. Every day, the research team informed the regional logistic team in charge of planning the health resources, who programmed the ward and ICU beds based on the resulting predictions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis paper has been supported by grant MTM2016-77015-R (AEI, FEDER EU). The authors are grateful to the medical staff of the main hospital in Navarre for providing data and validating the simulation model.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Public University of NavarreAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesHistorical data is available on publicly accessible web pages. The patient data used in the case study is not authorized to be made public. https://coronavirus.jhu.edu/map.html https://ec.europa.eu/info/live-work-travel-eu/health/coronavirus-response_en https://www.who.int/emergencies/diseases/novel-coronavirus-2019 https://www.worldometers.info/coronavirus/